← Open Payments lookup

BRIDGET DUNN: Open Payments

NPI 1841706306 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$427 in 20 payments from 10 companies in 2025. Trend: 2023 $1,018 · 2024 $1,172 · 2025 $427

Food & beverage: $427
CompanyPaymentsAmount
Astellas Pharma US Inc4$101
Novo Nordisk Inc3$68
AstraZeneca Pharmaceuticals LP4$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$63
Lilly USA, LLC2$42
ABBVIE INC.1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Inspire Medical Systems, Inc.1$19
GlaxoSmithKline, LLC.1$17
Amgen Inc.1$15

Products named: Veozah, CAPLYTA, Ozempic, MOUNJARO, BREZTRI, AIRSUPRA, VRAYLAR, JARDIANCE.

Industry payments across PA — which companies pay providers there.